Skip to Content

New US Assistant Secretary of Health Is First Openly Transgender Federal Official

THURSDAY, March 25, 2021 -- Rachel Levine, M.D., has been confirmed by the U.S. Senate as assistant secretary of health, becoming the first openly transgender federal official to win Senate confirmation.

The vote Wednesday was 52-48 and the result was mostly along party lines. Only two Republicans -- Sens. Lisa Murkowski of Alaska and Susan Collins of Maine -- voted with all Democrats in supporting Levine, the Associated Press reported. Levine, who had been Pennsylvania health secretary since 2017, is expected to be in charge of Health and Human Services offices and programs nationwide.

Levine's achievement is considered a historic breakthrough by transgender-rights activists because few trans people have held high-level state or federal offices, the AP reported.

A graduate of Harvard and of Tulane Medical School, Levine is president of the Association of State and Territorial Health Officials. She has written in the past on the opioid crisis, medical marijuana, adolescent medicine, eating disorders, and LGBTQ medicine, the AP reported.

Associated Press Article

© 2021 HealthDay. All rights reserved.

Read this next

Grandmaternal DDT Exposure Tied to Granddaughter Early Menarche, Obesity

FRIDAY, April 16, 2021 -- Grandmaternal perinatal serum dichlorodiphenyltrichloroethane (DDT) is associated with granddaughter adult obesity and early menarche, according to a...

Brain Activity May Play Role in 'Broken Heart Syndrome'

FRIDAY, April 16, 2021 -- Researchers may have uncovered potential mechanisms contributing to "broken heart syndrome," according to a study published online March 26 in the...

Response to One COVID-19 Vaccine Dose Strong in Previously Infected

FRIDAY, April 16, 2021 -- For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.